You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cetuximab-irdye800

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, High-grade Glioma Trial in Groningen (Cetuximab-IRDye800)

Recruiting
  • Glioblastoma
  • High-grade Glioma
  • Cetuximab-IRDye800
  • Groningen, Netherlands
    UMCG
Jun 26, 2023

Lung Cancer, Video-assisted Thoracic Surgery, EGFR Trial in Torino (Cetuximab-IRDye800)

Not yet recruiting
  • Lung Cancer
  • +3 more
  • Cetuximab-IRDye800
  • Torino, TO, Italy
    Azienda Ospedaliera Universitaria Città della Salute e della Sci
Oct 23, 2023

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Groningen (Fluorescence guided detection of tumor positive

Not yet recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Fluorescence guided detection of tumor positive margins
  • Cetuximab-IRDye800
  • Groningen, Netherlands
    University Medical Center Groningen
Aug 10, 2022

Rectal Cancer Trial in Groningen (Cetuximab-IRDye800, Fluorescent molecular endoscopy and surgery)

Recruiting
  • Rectal Cancer
  • Cetuximab-IRDye800
  • Fluorescent molecular endoscopy and surgery
  • Groningen, Netherlands
    University Medical Center Groningen
Nov 16, 2020

Drug Safety ; Drug Specificity Trial in Zhuhai (Cetuximab-IRDye800)

Unknown status
  • Drug Safety ; Drug Specificity
  • Cetuximab-IRDye800
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Nov 12, 2019

Head Neck Cancer Trial in Stanford (Cetuximab-IRDye800)

Terminated
  • Head and Neck Cancer
  • Cetuximab-IRDye800
  • Stanford, California
    Stanford University, School of Medicine
Jun 21, 2019

Pancreatic Adenocarcinoma Trial in Stanford (Cetuximab-IRDye800, Cetuximab)

Terminated
Has Results
  • Pancreatic Adenocarcinoma
  • Stanford, California
    Stanford University School of Medicine
Jun 21, 2019